Skip to main content
HR 2550 118th Congress House Health

Special Diabetes Program Reauthorization Act of 2023

Introduced: May 11, 2023 Introduced by: DeGette, Diana Democratic · Colorado See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 21, 2023
Referred to the Subcommittee on Health.
Apr 10, 2023
Introduced in House
Apr 10, 2023
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Special Diabetes Program Reauthorization Act of 2023

This bill extends funding through FY2028 for a program carried out by the National Institute of Diabetes and Digestive and Kidney Diseases that supports research on the prevention and cure of type 1 diabetes.

What's happening now April 21, 2023

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 4

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • VENABLE LLP
    for THE DIATRIBE FOUNDATION · California · 4th Quarter (Oct 1 - Dec 31) 2025
  • VENABLE LLP
    for THE DIATRIBE FOUNDATION · California · 3rd Quarter (July 1 - Sep 30) 2025
  • VENABLE LLP
    for THE DIATRIBE FOUNDATION · California · 2nd Quarter (Apr 1 - June 30) 2025
  • VENABLE LLP
    for THE DIATRIBE FOUNDATION · California · 1st Quarter (Jan 1 - Mar 31) 2025
 Cosponsors 8
All 8 Democratic 5 Republican 2
D
Leger Fernandez, Teresa
New Mexico · Sep 12, 2023
 D
Tlaib, Rashida
Michigan · Aug 29, 2023
 D
Doggett, Lloyd
Texas · Jun 21, 2023
Pascrell, Bill
· May 11, 2023
 D
Castor, Kathy
Florida · May 10, 2023
 D
Schrier, Kim
Washington · May 10, 2023
 R
Cole, Tom
Oklahoma · Apr 18, 2023
 R
Bilirakis, Gus M.
Florida · Apr 10, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2550: Special Diabetes Program Reauthorization Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-2550/
MLA
"H.R. 2550: Special Diabetes Program Reauthorization Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-2550/.
Bluebook (legal)
H.R. 2550, 118th Cong. (2026), https://openamerica.io/bill/118-HR-2550/.
Markdown link
[H.R. 2550: Special Diabetes Program Reauthorization Act of 2023](https://openamerica.io/bill/118-HR-2550/)
Report a problem